TRANSLATIONAL LUNG CANCER RESEARCH : Impact Factor & More
eISSN: 2226-4477pISSN: 2218-6751
Share this on:
Key Metrics
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on TRANSLATIONAL LUNG CANCER RESEARCH
TRANSLATIONAL LUNG CANCER RESEARCH Journal Specifications
| Overview | |
| Publisher | AME PUBLISHING COMPANY |
| Language | English |
| Frequency | Bi-monthly |
| General Details | |
| Language | English |
| Frequency | Bi-monthly |
| Publication Start Year | 2012 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in TRANSLATIONAL LUNG CANCER RESEARCH ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in TRANSLATIONAL LUNG CANCER RESEARCH
Adjuvant epidermal growth factor receptor tyrosine kinase inhibitor in resected stage N2 non-small cell lung cancer harboring EGFR mutation.
- 31 May 2026
- Translational lung cancer research
BTLA and PD-1 combined with radiotherapy for enhancing antitumor immune response in lung cancer via the regulation of memory B cells to promote T-cell infiltration
- 26 May 2026
- Translational Lung Cancer Research
Development and external validation of a multivariable nomogram for predicting severe immune checkpoint inhibitor-associated myocarditis in advanced lung cancer
- 26 May 2026
- Translational Lung Cancer Research
ZNF528 as a novel driver of metastasis in lung cancer: insights from single-cell transcriptomics
- 26 May 2026
- Translational Lung Cancer Research
Dynamic changes in liver-to-spleen ratio: can it be a prognostic biomarker for chemo-immunotherapy in small cell lung cancer?
- 26 May 2026
- Translational Lung Cancer Research
Real-world outcomes of consolidative durvalumab after concurrent chemoradiotherapy in stage III non-small cell lung cancer: the prognostic role of clinical frailty in the post-PACIFIC era
- 26 May 2026
- Translational Lung Cancer Research
Adjuvant epidermal growth factor receptor tyrosine kinase inhibitor in resected stage N2 non-small cell lung cancer harboring EGFR mutation.
- 31 May 2026
- Translational lung cancer research
BTLA and PD-1 combined with radiotherapy for enhancing antitumor immune response in lung cancer via the regulation of memory B cells to promote T-cell infiltration
- 26 May 2026
- Translational Lung Cancer Research
Development and external validation of a multivariable nomogram for predicting severe immune checkpoint inhibitor-associated myocarditis in advanced lung cancer
- 26 May 2026
- Translational Lung Cancer Research
ZNF528 as a novel driver of metastasis in lung cancer: insights from single-cell transcriptomics
- 26 May 2026
- Translational Lung Cancer Research
Dynamic changes in liver-to-spleen ratio: can it be a prognostic biomarker for chemo-immunotherapy in small cell lung cancer?
- 26 May 2026
- Translational Lung Cancer Research
Real-world outcomes of consolidative durvalumab after concurrent chemoradiotherapy in stage III non-small cell lung cancer: the prognostic role of clinical frailty in the post-PACIFIC era
- 26 May 2026
- Translational Lung Cancer Research
FAQs on TRANSLATIONAL LUNG CANCER RESEARCH
How long has TRANSLATIONAL LUNG CANCER RESEARCH been actively publishing? 
What is the publishing frequency of TRANSLATIONAL LUNG CANCER RESEARCH?
How many articles did TRANSLATIONAL LUNG CANCER RESEARCH publish last year?
What is the eISSN & pISSN for TRANSLATIONAL LUNG CANCER RESEARCH?
Who is the publisher of TRANSLATIONAL LUNG CANCER RESEARCH?
